tirzepatide uric acid reduction study UC Irvine researchers project cardiac benefits from weight-loss medication Metabolic Health
Description
Regular follow-up appointments will help track your improvements and address any concerns
H., Lee, S
The SURMOUNT-1 trial randomized 2500 obese prediabetics to tirzepatide or placebo
However, tirzepatide may cause slightly more gastrointestinal distress at higher doses, especially during the initial weeks of treatment
